利伐沙班国内的价格

The recommended dose of rivaroxaban is 10 mg orally, once daily. If the wound has stopped bleeding, the first medication should be administered between 6 and 10 hours after surgery. The length of treatment is determined by each patient's risk of VTE, i.e. by the type of orthopedic surgery the patient has undergone. For patients undergoing major hip surgery, a recommended course of treatment is 5 weeks. For patients undergoing major knee surgery, a recommended course of treatment is 2 weeks. If a dose is missed, the patient should take rivaroxaban immediately and continue taking it once daily the next day. Patients can take rivaroxaban with a meal or on its own. Today we will learn about the domestic price of rivaroxaban.

The price and specifications of rivaroxaban are different: 1. The selling price of rivaroxaban in the United States: Specification: 10mg-10 tablets/box, pharmacy price: US$156.24; Specification: 15mg-30 tablets/box, pharmacy price: US$438.67; Specification: 20mg-30 tablets/box, pharmacy price: US$553.65. 

2. The price of rivaroxaban in China: Domestic rivaroxaban is the original drug produced by Bayer Pharma AG/Germany Bayer Pharmaceuticals. Specification: 10mg-5 tablets/box, priced at about 138$; Specification: 15mg-7 tablets/box, priced at about 199$; Specification: 20mg-7 tablets/box, priced at about 263$. 

3. The specifications of rivaroxaban available abroad are 15mg*28 tablets; the price of 20mg*28 tablets is around $600. Please consult Medical Companion Travel for price details.

Common adverse reactions include nausea, increased GGT and increased transaminases. Adverse effects should be explained in the context of surgery. Due to its pharmacological mode of action, rivaroxaban may cause an increased risk of latent or overt bleeding in some tissues or organs, possibly resulting in posthemorrhagic anemia. The signs, symptoms, and severity of bleeding (including possible fatal consequences) will vary depending on the location, extent, or extent of the bleeding. The risk of bleeding may be increased in certain patient groups, such as patients with uncontrolled severe arterial hypertension and/or patients receiving concomitant medications that affect hemostasis. Hemorrhagic complications may manifest as weakness, weakness, pallor, dizziness, headache, or unexplained swelling. Therefore, the possibility of bleeding should be considered when evaluating patients taking anticoagulants.

The above is the price of rivaroxaban, I hope it can help you!